AndrewJCarterDO

PubMed

• Facility-based approach for the management of acute ST segment elevation myocardial infarction with cardiogenic shock in a rural medical centre: the Durango model.
  Lane, L., LeSage, L., Langenhorst, S., Dempsey, M., Hughes, D., Gleason, M., Weiss, S., Carter, A., Raffoul, J., Smolin, M., Anderson, W.> ;Open Heart. 2023 Dec 7
• 8 citations
  Drug-eluting stent fracture promise and performance.
  Andrew J. Carter> ;Journal of the American College of Cardiology. 2009 Nov 17
• 151 citations
  Drug-Eluting Stents in Preclinical Studies Updated Consensus Recommendations for Preclinical Evaluation
  Robert S. Schwartz, Elazer R. Edelman, Renu Virmani, Andrew J. Carter, Juan F. Granada, Greg L. Kaluza, Nicolas Chronos, Keith A. Robinson, Ron Waksman, Judah Weinberg...> ;Circulation. Cardiovascular Interventions. 2008 Oct 1
• 10 citations
  Stent strut fracture: seeing is believing.
  Andrew J. Carter> ;Catheterization and Cardiovascular Interventions. 2008 Apr 1
• 66 citations
  The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional regist...
  Hitinder S. Gurm, Dean E. Smith, J. Stewart Collins, David Share, Arthur Riba, Andrew J. Carter, Thomas LaLonde, Eva Kline-Rogers, Michael O'Donnell, Hameem Changezi, ...> ;Journal of the American College of Cardiology. 2008 Feb 5
• 9 citations
  Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascula...
  Hitinder S. Gurm, Dean E. Smith, Stan Chetcuti, David Share, Sanjaya Khanal, Arthur Riba, Andrew J. Carter, Thomas LaLonde, Eva Kline-Rogers, Michael O'Donnell, Willia...> ;Journal of Interventional Cardiology. 2007 Jun 1
• 1 citations
  Late atheromatous degeneration of neointima after coronary stenting: An ounce of prevention
  Andrew J. Carter> ;Catheterization and Cardiovascular Interventions. 2006 Oct 1
• 7 citations
  Coronary artery rupture during balloon angioplasty, rescued with localized thrombin injection and coil embolization
  Tim A. Fischell, Andrew J. Carter, Kamal Ashraf, Joseph Birdsall, Sandy Smoker> ;Catheterization and Cardiovascular Interventions. 2006 Aug 1
• 39 citations
  Experimental efficacy of an everolimus eluting cobalt chromium stent
  Andrew J. Carter, Anastasia Brodeur, Robin Collingwood, Sarah Ross, Lori Gibson, Chi-An Wang, Scott Haller, Leslie Coleman, Renu Virmani> ;Catheterization and Cardiovascular Interventions. 2006 Jul 1
• The use of multiple coronary guidewires to occupy secondary branch vessels and facilitate PCI of a complex aneurysmal stenosis.
  Satyauardhan Pulukurthy, Andrew J. Carter> ;Catheterization and Cardiovascular Interventions. 2006 Mar 1
• 23 citations
  Intravascular Ultrasound Characterization of the “Black Hole” Phenomenon After Drug-Eluting Stent Implantation
  Marco A. Costa, Manel Sabaté, Dominick J. Angiolillo, Pilar Jiménez-Quevedo, Paul S. Teirstein, Andrew J. Carter, Jeffrey W. Moses, Martin M. Zenni, Steven J. Yakubov,...> ;The American Journal of Cardiology. 2006 Jan 15
• 1 citations
  Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.
  Andrew J. Carter> ;Catheterization and Cardiovascular Interventions. 2005 Dec 1
• 16 citations
  Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.
  Marco A. Costa, Dominick J. Angiolillo, Paul S. Teirstein, Paul Gilmore, Jeffrey W. Moses, Steven J. Yakubov, Andrew J. Carter, Tim A. Fischell, Martin Zenni, Theodore...> ;The Journal of Invasive Cardiology. 2005 Aug 1
• 22 citations
  Stent‐based delivery of ABT‐578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model
  Robin Collingwood, Lori Gibson, Souad Sedlik, Renu Virmani, Andrew J. Carter> ;Catheterization and Cardiovascular Interventions. 2005 Jun 1
• 7 citations
  Segmental vessel wall shear stress and neointimal formation after sirolimus-eluting stent implantation: physiological insights in a porcine coronary model☆
  Andrew J. Carter, Wei Wei, Lori Gibson, Robin Collingwood, Fermin O. Tio, John Dooley, Gregory A. Kopia> ;Cardiovascular Revascularization Medicine. 2005 Apr 1
• 7 citations
  Impact of frame selection on quantitative coronary angiographic analysis after coronary stenting
  Tim A. Fischell, Alok Maheshwari, Rubina A. Mirza, Scott Haller, Andrew J. Carter, Jeffrey J. Popma> ;Catheterization and Cardiovascular Interventions. 2005 Apr 1
• 1 citations
  Unprotected left main stenting: an alternative to CABG in a DES world?
  Tim A. Fischell, Andrew J. Carter> ;The Journal of Invasive Cardiology. 2005 Mar 1
• 53 citations
  Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group.
  Robert S. Schwartz, Elazer R. Edelman, Andrew J. Carter, Nicolas A. Chronos, Campbell Rogers, Keith A. Robinson, Ron Waksman, Lindsay S. Machan, Judah Weinberger, Robe...> ;Circulation. 2004 Oct 19
• 221 citations
  Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model
  Andrew J. Carter, Meenakshi Aggarwal, Gregory A. Kopia, Fermin O. Tio, Philip S. Tsao, Ron Kolata, Alan C. Yeung, Gerald Llanos, John Dooley, Robert Falotico> ;Cardiovascular Research. 2004 Sep 1
• Initial experience with the novel 6 Fr-compatible system for debulking de novo coronary arterial lesions.
  Fumiaki Ikeno, Alexandre Abizaid, Takeshi Suzuki, Mehrdad Rezaee, Greg R. Patterson, Alan C. Yeung, Renu Virmani, J. Eduardo Sousa, Andrew J. Carter> ;Catheterization and Cardiovascular Interventions. 2004 Jul 1
• 11 citations
  Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 protein
  William F. Fearon, Fumiaki Ikeno, Lynn Bailey, Bonnie L. Hiatt, Niall A. Herity, Andrew J. Carter, Peter J. Fitzgerald, Mehrdad Rezaee, Alan C. Yeung, Paul G. Yock> ;Catheterization and Cardiovascular Interventions. 2004 Mar 1
• 33 citations
  TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?
  Andrew J. Carter> ;Catheterization and Cardiovascular Interventions. 2004 Feb 1
• 7 citations
  Comparison of developmental endothelial locus-1 angiogenic factor with vascular endothelial growth factor in a porcine model of cardiac ischemia
  Murray H Kown, Takeshi Suzuki, Mark L Koransky, Kalyani Penta, Gordon T. Sakamoto, Christina L Jahncke, Andrew J. Carter, Thomas Quertermous, Robert C. Robbins> ;The Annals of Thoracic Surgery. 2003 Oct 1
• 4 citations
  Stent-based immunosuppressive therapies for the prevention of restenosis.
  Meenakshi Aggarwal, Philip S. Tsao, Alan C. Yeung, Andrew J. Carter> ;Cardiovascular Radiation Medicine. 2003 Apr 1
• 117 citations
  Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given ...
  David P. Lee, Niall A. Herity, Bonnie L. Hiatt, William F. Fearon, Mehrdad Rezaee, Andrew J. Carter, Michelle Huston, Donald Schreiber, Peter M. DiBattiste, Alan C. Yeung> ;Circulation. 2003 Mar 25
• Join now to see all

Books/Book Chapters

• Textbook of Coronary Stenting 
  Chapter: Sirolimus Eluting Stent: Preclinical Studies. 
  Carter AJ, Kopia G, Falotico REditors: Stone GW and Leon MB.W. B. Saunders, Philadelphia, PA2007
• Handbook of Drug-eluting Stents. 
  Chapter: Histopathology of Restenosis. 
  Page 15 - 25Carter AJ, Tsao PEditors: Serruys PW and Girshlick A.Taylor and Francis, United Kingdom2005
• Handbook of Drug-eluting Stents. 
  Chapter: Sirolimus Eluting Stent: Preclinical Studies. 
  Page 93 - 103Carter AJ, Kopia G, Falotico REditors: Serruys PW and Girshlick A.Taylor and Francis, United Kingdom2005
• Handbook of Vulnerable Plaque 
  Chapter: Emerging Animal Models of Vulnerable Plaque. 
  Page 153 - 171Carter AJ, Wei WEditors: Serruys PW and Waksman R.Taylor and Francis, United Kingdom2004
• Drug Eluting Stent: Drug Eluting Stents in the Real World and the Clinical Results. 
  Chapter: Drug Eluting Stent Results in the Preclinical Studies. 
  Page 51 - 60Suzuki T, Carter AJMedical College Press, Japan2004
• Vascular Brachytherapy 
  Chapter: Lessons from the Feasibility Radioactive (IRIS) Stent Trials. 
  Page 441 - 451Fischell TA, Carter AJ, Foster M, Fischell RE, Fischell DREditors: Waksman R.Futura, NYEdition 3rd,2002
• Handbook of Coronary Stents 
  Chapter: Rapamycin Coated Stent. 
  Page 349 - 359Carter AJ, Falotico REditors: Serruys PW and Girshlick A.Martin Dunitz, The NetherlandsEdition 4th,2002
• Vascular Injury: Preclinical Studies. 
  Chapter: Atherosclerotic Porcine Coronary Stent Model: Technical Methods for Preclinical Studies. 
  Page 43 - 51Carter AJEditors: Simon DI and Rogers C.Humana Press Cardiology Series2001
• Vascular Brachytherapy 
  Chapter: Long-term effects of radioactive stents in experimental models. 
  Page 343 - 351Carter AJEditors: Waksman R.Futura, NYEdition 2nd,1999
• Vascular Brachytherapy 
  Chapter: Pathology of Radioactive Stents. 
  Page 353 - 363Virmani R, Carter AJ, Jones RM, Farb AEditors: Waksman R.Futura, NYEdition 2nd,1999
• Vascular Brachytherapy 
  Chapter: Lessons from the Feasibility Radioactive (IRIS) Stent Trials. 
  Page 475 - 481Fischell TA, Carter AJ, Foster M, Fischell RE, Fischell DREditors: Waksman R.Futura, NYEdition 2nd,1999
• Handbook of Vascular Brachytherapy. 
  Chapter: The Isostent Balloon Expandable Coronary Stent. 
  Page 59 - 67Fischell DR, Fischell TA, Fischell RE, Foster MT, Carter AJEditors: Waksman R, Serruys PW.Martin Dunitz, The Netherlands1998
• Handbook of Coronary Stents 
  Chapter: The Isostent Balloon Expandable Coronary Stent. 
  Page 213 - 219Fischell DR, Fischell TA, Fischell RE, Turnlund T, Carter AJEditors: Kutryk, M, Serruys PW.Martin Dunitz, The Netherlands1997
• Endoluminal Stenting 
  Chapter: Experimental observations with stents in canine and porcine coronary models. 
  Page 16 - 26Virmani R, Carter AJ, Farb A, Laird JR, Zidar JP, Stack RS, Reeves T, Yaklavich MEditors: Sigwart, U.WB Saunders, Philadelphia1996
• Vascular Brachytherapy 
  Chapter: A Beta Particle Emitting Radioisotope Stent for the Prevention of Restenosis. 
  Fischell TA, Laird JR, Carter AJ, Virmani R, Fischell DR, Fischell REEditors: Waksman, R, King SB, Crocker IR, Mould RF.Nucleotron, The NetherlandsEdition 1st,1996
• Join now to see all

Abstracts/Posters

• Clinical, Angiographic and IVUS Results from the Pivotal United States Spirit III Trial of the Xience™ V Everolimus Eluting Coronary Stent System in Patients with Coro...
  Stone G, Sood P, Midei M, Newman W, Sanz M, Hermiller J, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, Kereiakes D, Carter A, Williams D, Fortun..., Late Breaking Clinical Trial, American College of Cardiology Annual Scientific Session, New Orleans, LA, 3/24/2007
• The Effects of a Diffusion Barrier on the Elution Characteristics of ABT-578 via a Phosphorylcholine Matrix.
  Carter AJ, Brodeur A, Hasting E, Gibson L, Collingwood R, Ross S, Johnson M, Melder RJ, J Am Coll Cardiol, 1/1/2006
• The Safety and Efficacy of Elective Percutaneous Coronary Intervention (PCI) Using Bivalirudin Versus Heparin and Glycoprotein IIbIIIa Inhibitors: Insight from the Blu...
  Gurm H, Smith D, Khanal S, Riba A, Carter AJ, LaLonde T, Kline-Rogers EM, Moscucci M, J Am Coll Cardiol, 1/1/2006
• Increased Expression of eNOS by Endeavor, Zotarolimus Eluting Stents Compared to Other DES in Porcine Coronary Artery Implants.
  Haraguchi G, Pruitt S, Brodeur A, Collingwood R, Carter AJ, Melder R, Wilcox C, Am J Cardiol, 1/1/2006
• In-vivo Performance of a Novel Co-polymer System for Extended Release of Zotarolimus in a Second Generation Drug-eluting Stent.
  Carter AJ, Melder R, Udipi K, Ozdil F, Virmani R, Wilcox JN, Am J Cardiol, 1/1/2006
• Phramacokinetics and Pharmacodynamics of Stent-based Delivery of Sirolimus via a Novel Metallic Anisotropic Nanoporous Surface Coating.
  Carter AJ, Lye WK, Wamhoff B, Christians U, Tio F, Owens GK, Circulation, 1/1/2006
• Experimental Feasibility and Efficacy of a Novel Modular Segmented Stent with In-situ Programmable Length and Drug Elution from a Biodegradable Polymer Coating.
  Carter AJ, Gibson L, Haller S, Brodeur A, Collingwood R, Ross S, Marco P, Tio F, Robinson K, Am J Cardiol, 1/1/2005
• Dose Response Effects of a Novel Slow-release Polymeric ABT-578 Eluting Stent.
  Carter AJ, Brodeur A, Hasting E, Gibson L, Collingwood R, Ross S, Caceres A, Jones R, Johnson M, Udipi K, Ozdil F, Melder RJ, Virmani R, Wilcox JN, Circulation, 1/1/2005
• Similar Outcomes Between Patients with Native and Coronary Bypass Graft Disease Treated with Sirolimus Eluting Stents in the SECURE Trial.
  Costa M, Teirstein P, Leon MB, Bass T, Fischell T, Carter A, Yakubov S, J Am Coll Cardiol, 1/1/2004
• Initial Experience with Sirolimus Eluting Stents in Left Main no Option Patients: Data from the SECURE Trial.
  Yakubov S, Teirstein P, Leon MB, Bass T, Costa M, Carter AJ, Fischell T, J Am Coll Cardiol, 1/1/2004
• Sirolimus Eluting Stents for failed Brachytherapy: results from the SECURE Registry.
  Teirstein P, Bass TA, Costa MA, Yakubov S, Carter AJ, Moses JW, Leon MB, Mehran R, Price MJ, Fischell TA, J Am Coll Cardiol, 1/1/2004
• Intravascular Ultrasound Follow-up of the SECURE Trial: The Compassionate Use of Sirolimus Elutings Stents Study.
  Talwar K, Costa M, Teirstein P, Yakubov S, Carter AJ, Leon MB, Moses JW, Bass T, J Am Coll Cardiol, 1/1/2004
• Characterization of Neointimal Hyperplasia After Sirolimus Eluting Stent Implantation in Patients with Previous Brachytherapy Failure: Insights from the SECURE Study.
  Costa M, Talwar K, Panse N, Teirstein P, Yakubov S, Carter AJ, Bass T, Gilmore P, J Am Coll Cardiol, 1/1/2004
• Comparative Efficacy of Everolimus and Sirolimus Delivered via Polymeric Drug Eluting Stents in the Porcine Coronary Model.
  Carter AJ, Wang CA, Royal J, Coleman L, Gibson L, Rossi A, Booth J, Jones R, Virmani R, J Am Coll Cardiol, 1/1/2004
• Use of the Sirolimus-Eluting Bx Velocitytm Stent in Insulin Dependent Diabetics with Refractory Restenosis: Results from the SECURE Registry.
  Kao J, Teirstein PS, Moses JW, Leon MB, Yakubov S, Carter AJ, Circulation, 1/1/2004
• Stents Coated with the Lipophilic Compound A24 Profoundly Inhibit Neointimal Formation in the Porcine Coronary Model.
  Carter AJ, Welch L, Gibson L, Sedlik S, Virmani R, J Am Coll Cardiol, 1/1/2003
• Sirolimus-Eluting Stent for the Treatment of Bypass Graft Disease: The Initial U. S. Experience.
  Costa M, Moses JW, Leon MB, Teirstein PS, Yakubov S, Carter AJ, Fischell TA, Bass TA, J Am Coll Cardiol, 1/1/2003
• Chronic Stent-Induced Injury and Inflammation results in Sustained Activation of the Cell Cycle in the Porcine Model.
  Aggarwal M, Tsao P, Kopia G, Glassford A, Yeung AC, Tio F, Carter AJ, J Am Coll Cardiol, 1/1/2003
• Use of the Sirolimus-Eluting Bx Velocity Stent for Failed Brachytherapy in Recurrent In-Stent Restenosis: Results from The Secure Registry.
  Teirstein PS, Kao J, Bass T, Costa MA, Yakubov S, Carter AJ, Moses JW, Leon MB, Fischell TA, J Am Coll Cardiol, 1/1/2003
• Experimental Evaluation of a Novel Balloon Expandable Stent and Delivery System for treatment of Coronary Bifurcation Lesions.
  Carter AJ, Ambrose D, Gibson L, Welch L, Coleman L, Virmani R, J Am Coll Cardiol, 1/1/2003
• Use of the Sirolimus-Eluting Bx Velocity Stent for Failed Brachytherapy in Recurrent In-Stent Restenosis: Results from The Secure Registry.
  Teirstein PS, Moses JW, Leon MB, Kao J, Bass TA, Costa MA, Yakubov S, Fischell TA, Carter AJ, Circulation, 1/1/2003
• Sirolimus-Eluting Stent for the Treatment of Bypass Graft Disease; Long-term results of the Initial US Experience.
  Costa M, Gilmore P, Carter A, Teirstein P, Yakubov S, Sasseen B, Zenni M, Fischell T, Bass TA, Circulation, 1/1/2003
• Intravascular Ultrasound Follow-up of the SECURE Trial: The Compassionate Use of Sirolimus-Eluting Stent Study.
  Costa MA, Panse N, Teirstein P, Carter A, Yakubov S, Gilmore P, Zenni M, Sasseen B, Bass TA, Circulation, 1/1/2003
• High Pressure, Retrograde, Coronary Venous Delivery of FGF-2 Protein Improves Coronary Blood Flow in a Porcine Model of Myocardial Ischemia.
  Fearon W, Rezaee M, Hiatt B, Ikeno F, Bailey L, Suzuki T, Herity N, Fitzgerald PJ, Carter AJ, Yeung AC, Yock PG, J Am Coll Cardiol, 1/1/2002
• Acute and Long-term Safety of Pressurized Myocardial Transvenous Delivery: Confirmation by Biochemical, Echocardiographic, and Histologic Parameters.
  Herity N, Hiatt B, Fearon W, Suzuki T, Yeung AC, McEneaney DJ, Berry G, Carter AJ, Fitzgerald PJ, Yock PG, J Am Coll Cardiol, 1/1/2002
• Join now to see all

Lectures

• Specialized Stents for Specialized Situations. Drug Eluting Stents 2008. 
  3/31/2008
• New Polymeric Coatings. Emerging Technologies: Stents. 
  Chicago, IL - 3/29/2008
• Moderator, Novel Drug Eluting Stents. 
  Washington, DC - 10/21/2007
• Preclinical Evaluation of the Xtent Modular Segmented Drug Eluting Stent. 
  Barcelona, Spain - 5/25/2007
• Novel Stents. 
  New Orleans, LA - 3/25/2007
• Pathology of Drug Eluting Stents. 
  New Orleans, LA - 3/25/2007
• Drug Eluting Stents for the Prevention of SFA Restenosis: Will this ever happen? 
  New Orleans, LA - 3/25/2007
• Early and late effects of Polymers on the Vessel Wall. 
  Washington, DC - 3/9/2007
• Bioabsorbable Stents: Basic Design Concepts. 
  Washington, DC - 3/9/2007
• Moderator, Update on Research, Development, and Regulatory Issues with Biodegradable Stents. 
  Washington, DC - 3/9/2007
• Co-chairman, From bench to clinics: Models to assess vascular healing response: from wound healing to vascular re-endothelialization. 
  Geneva, Switzerland - 2/2/2007
• Coronary Vasomotor Function and DES: Insights into Mechanisms and Pathophysiology of Coronary Arterial Function with DES Formulations in Experimental Models. 
  Geneva, Switzerland - 2/2/2007
• Assessment of biological compatibility of polymers. 
  Geneva, Switzerland - 2/2/2007
• Rationale for Combination Drug-eluting Stents: Advantages and Pitfalls. 
  Washington, DC - 10/26/2006
• Early and Late Effects of Durable and Biosorbable Polymers on the Vessel Wall. DES Next Generation Basic Science Workshop. 
  Washington, DC - 10/24/2006
• Symposium co-chairman, DES Next Generation Basic Science Workshop. 
  Washington, DC - 10/23/2006
• Comparative Experimental Findings of Polymers and Drugs: Are there differences between the current drug eluting stents in clinical use and investigation? DES Next Gene... 
  Washington, DC - 10/23/2006
• Have you seen a bifurcation lesion? Perspectives from an anatomopatholgist. 
  Rome, Italy - 9/26/2006
• DES Spirit of XIENCE stent. 
  Singapore - 2/27/2006
• Moderator, Complications of Drug Eluting Stents: Late Stent Thrombosis. 
  Singapore - 2/27/2006
• Prevention of Restenosis: DES with Semisynthetic or Novel Polymers: Experimental Data. 
  Geneva, Switzerland - 2/3/2006
• Cell Recruitment for Stent Reendothelialization: Experimental Data for the anti-CD34 Stent. 
  Geneva, Switzerland - 2/3/2006
• Drug-eluting Stents: "Next Generation" Basic Science Workshop, Symposium Co-chairman 
  Washington, DC - 10/17/2005
• Non-polymeric Methods for Stent-based Drug Delivery. 
  Washington, DC - 10/17/2005
• Polymer Interactions with the Vessel Wall. 
  Washington, DC - 10/17/2005
• Join now to see all

Other

• Methods and Kits for Locally Administering an Active Agent to an Interstitial Space of a Host 
  Carter A, U.S. Patent No. 6,346,098
• Anti-inflammatory Drug and Delivery Device 
  Carter A, U.S. Patent No. 6,776,796
• Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease 
  Carter A, U.S. Patent No. 8236048 B2